These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18437332)

  • 1. Aldosterone in salt-sensitive hypertension and metabolic syndrome.
    Fujita T
    J Mol Med (Berl); 2008 Jun; 86(6):729-34. PubMed ID: 18437332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome.
    Fujita T
    Hypertension; 2010 Apr; 55(4):813-8. PubMed ID: 20176994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.
    Nagase M
    Clin Exp Nephrol; 2010 Aug; 14(4):303-14. PubMed ID: 20533072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
    Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Aldosterone in Obesity-Related Hypertension.
    Kawarazaki W; Fujita T
    Am J Hypertens; 2016 Apr; 29(4):415-23. PubMed ID: 26927805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury.
    Ayuzawa N; Fujita T
    J Am Soc Nephrol; 2021 Feb; 32(2):279-289. PubMed ID: 33397690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway.
    Shibata S; Mu S; Kawarazaki H; Muraoka K; Ishizawa K; Yoshida S; Kawarazaki W; Takeuchi M; Ayuzawa N; Miyoshi J; Takai Y; Ishikawa A; Shimosawa T; Ando K; Nagase M; Fujita T
    J Clin Invest; 2011 Aug; 121(8):3233-43. PubMed ID: 21765214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
    Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.
    Ronconi V; Turchi F; Appolloni G; di Tizio V; Boscaro M; Giacchetti G
    Curr Vasc Pharmacol; 2012 Mar; 10(2):238-46. PubMed ID: 22022770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome.
    Hattori T; Murase T; Takatsu M; Nagasawa K; Matsuura N; Watanabe S; Murohara T; Nagata K
    J Am Heart Assoc; 2014 Dec; 3(6):e001312. PubMed ID: 25468654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mineralocorticoid action in the brain in salt-sensitive hypertension.
    Oki K; Gomez-Sanchez EP; Gomez-Sanchez CE
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):90-5. PubMed ID: 21585422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kidneys and aldosterone/mineralocorticoid receptor system in salt-sensitive hypertension.
    Shibata S; Fujita T
    Curr Hypertens Rep; 2011 Apr; 13(2):109-15. PubMed ID: 21207253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.
    Susic D; Varagic J; Frohlich ED
    Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1177-81. PubMed ID: 20118410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
    Whaley-Connell A; Johnson MS; Sowers JR
    Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of aldosterone in the metabolic syndrome.
    Briet M; Schiffrin EL
    Curr Hypertens Rep; 2011 Apr; 13(2):163-72. PubMed ID: 21279740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
    Kawarazaki H; Ando K; Fujita M; Matsui H; Nagae A; Muraoka K; Kawarasaki C; Fujita T
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1402-9. PubMed ID: 21478481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salt-sensitive hypertension in chronic kidney disease: distal tubular mechanisms.
    Bovée DM; Cuevas CA; Zietse R; Danser AHJ; Mirabito Colafella KM; Hoorn EJ
    Am J Physiol Renal Physiol; 2020 Nov; 319(5):F729-F745. PubMed ID: 32985236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.